This CXCL9/10/11-CXCR3 axis activation can lead to upregulated expression of the immunosuppressor programmed death-ligand 1 (PD-L1) by activating the STAT and PI3K-Akt signaling pathways that play an important role in cancer treatment (39). This evidence concerns the gene AKT1 and cancer.